Hot selling high purity synergistic weight management peptide cagrilintide

Name:Nancy
WhatsApp:+86 19831965506
Email Address:nancy@xtdaxiang.cn

   Cagrilintideis an amylin-analog, now being developed in combination with the GLP-1 semaglutide to achieve sustained weight loss in persons with overweight and obesity. Amylin, released with insu from beta cells in the pancreas, induces its satiating effect via both the homoeostatic and hedonic regions of the brain. Semaglutide reduces appetite via GLP-1 receptors in the hypothalamus and increases the production of insu, and reduces glucagon secretion, delaying gastric emptying. These separate, but related mechanisms of action of an amylin-analog . Given the heterogeneity and complex pathogenesis of obesity, combination therapy with multiple pathophysiological targets is a logical approach to increasing weight loss response with pharmacotherapy. Cagrilintide alone, as well as cagrilintide in combination with semaglutide have shown promising weight loss in clinical trials that supports the further development of this therapy for sustained weight management.

Appearance: Powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: To be determined

Shelf Life: >2 years if stored properly

Drug Formulation: To be determined

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

Cagrilintide is a long-acting synthetic amylin analog peptide designed to regulate human appetite, gastric emptying and systemic energy metabolism, primarily targeting long-term weight management for overweight and obese populations. Currently, it is undergoing extensive clinical research and co-development in combination with semaglutide, a classic GLP1 receptor agonist, to deliver superior, sustained weight loss effects compared to single-agent intervention.
As an amylin receptor agonist, Cagrilintide works through multi-pathway physiological regulation: it slows gastric emptying to prolong post-meal satiety, suppresses the brain’s central hunger signaling to reduce cravings for high-calorie, carbohydrate-rich foods, stabilizes postprandial blood glucose fluctuations, and lowers abnormal lipid accumulation in visceral fat tissue. These unique mechanisms perfectly complement the hypoglycemic and weight-lowering properties of GLP1 compounds like semaglutide, offsetting the common limitation of single GLP1 use—persistent hunger that often leads to weight rebound.
Both standalone Cagrilintide monotherapy and the Cagrilintide-semaglutide combination regimen have yielded highly encouraging outcomes across multiple phase clinical trials. Research data demonstrates that dual-target intervention delivers greater average body weight reduction, more effective control of waist circumference and visceral fat mass, and better long-term weight maintenance after treatment cycles. Trial results also confirm favorable tolerability profiles, with mild, transient gastrointestinal reactions as the most frequently reported side effects, far fewer severe adverse events associated with traditional weight-loss interventions.
Collectively, these robust clinical findings strongly validate the therapeutic potential of Cagrilintide, laying solid scientific groundwork for the continued advancement of this dual-action peptide therapy. It presents a novel, sustainable pharmaceutical strategy for addressing chronic overweight, clinical obesity, and related metabolic complications including insulin resistance and dyslipidemia. For research and laboratory applications, purified lyophilized Cagrilintide vials are widely adopted for preclinical metabolism studies, weight-loss mechanism exploration, and combined peptide formulation testing targeting metabolic disorder research.

When storing peptides, remember to:

• Store peptide in a cold, dry, dark place

• Avoid repeated freezing and thawing of peptide

• Avoid overexposure to the air

• Avoid light exposure

• Avoid storing peptides in solution long term

• Aliquot peptide according to experimental requirements

Why choose us?

Our Advantages:
1.High quality with competitive price.
2.All purity>99%.
3. We are manufacturer and can provide high quality products with factory price.
Fast and safe delivery:
1. Parcel can be sent out in 48 hours after payment tracking number available.
2. Secure and discreet shipment verious transportation methods for your choice.
3. Customs pass rate >99%.

FAQ:

Q1:  Can I get free samples?

A: Sure, we can provide a free sample, but client need afford the shipping fee.

Q2:  How do I know you can delivery success?

A: We will use discreet packing and door to door safe delivery method.

Q3:  What's your MOQ?

A: According to different products to decide, like may be 1g or 10g.

Q4:  How to contact us ?

A: You can choose your interested products and send inquiry to Us.

  Company profile

Daxiang Technology Co., Ltd., is a high-tech enterprise focusing on the research, development and production of peptide products. The company was established in recent years and is committed to applying advanced biotechnology to the health industry to meet the market's demand for high-quality, high-efficiency peptide products.​

As a leading peptide manufacturer, Daxiang Technology has a R&D team composed of senior scientists and engineers, which continues to explore and innovate, and is committed to developing safer, more effective, and more market-competitive peptide products. The company's main products cover but are not limited to pharmaceutical grade, food grade and cosmetic grade and other fields, and are widely used in many aspects such as health care, disease prevention, beauty and skin care.​

In terms of production technology, Daxiang Technology adopts internationally advanced production equipment and technology to ensure that every aspect of the product, from raw material selection, production and processing to finished product packaging, strictly follows relevant national standards and specifications to ensure product quality and safety. At the same time, the company has also established a complete quality management system and after-sales service system to provide customers with all-round, one-stop service support.​

Daxiang Technology adheres to the corporate philosophy of "technology leads health, quality creates the future" and always adheres to the development path of people-oriented and technological innovation. The company not only focuses on product quality and innovation, but also actively fulfills its social responsibilities and is committed to promoting the development and progress of the health industry.​

In the future,Daxiang Technology Co., Ltd. will continue to delve into the field of peptide product research and development, continue to explore and make breakthroughs, and strive to become a leader in the global peptide industry and make greater contributions to human health.